Eurepa 0.5 Tablet
By Eurepa
Rx
15 Tablet in a Strip

Composition
Repaglinide(0.5mg)

Manufacturer - Torrent Pharmaceuticals Ltd
Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Expires on or after
August, 2026
About Eurepa 0.5 Tablet
Eurepa 0.5 Tablet is a medication designed to help adults with type 2 diabetes mellitus manage their blood sugar levels effectively. It is often prescribed in conjunction with other diabetes medications to ensure proper control of blood sugar. By taking Eurepa 0.5 Tablet, patients can reduce the risk of severe complications associated with diabetes, such as kidney damage and blindness.
This tablet is typically recommended when diet and exercise alone or previous medications have not provided sufficient blood sugar control. For best results, it is advised to take Eurepa 0.5 Tablet before meals. The dosage will vary depending on the individual's condition and blood sugar levels, so it's crucial to follow the doctor's guidance. Consistency is key - taking the tablet at the same time every day maximizes its benefits.
It's essential to continue taking Eurepa 0.5 Tablet as directed by the healthcare provider, as the medication plays a vital role in managing blood sugar levels and preventing future complications. Along with medication, following a prescribed diet and exercise regimen is crucial for diabetes management. Monitoring for side effects is important; common ones include hypoglycemia, and contact with a healthcare provider is necessary if these side effects persist or cause concern.
Prior to starting Eurepa 0.5 Tablet, patients should inform their doctor about any history of kidney disease, heart issues, or pancreas problems, as well as alcohol consumption habits. Pregnant or breastfeeding individuals should consult their doctor before using the medication. It's also vital to disclose all other medications being taken, as there may be interactions that could affect the effectiveness of Eurepa 0.5 Tablet. Regular monitoring through tests like kidney function and blood glucose levels is typically required to ensure the medication is working properly.
Benefits
Eurepa 0.5 Tablet offers several benefits in the management of Type 2 diabetes mellitus. This medication enhances the production of insulin in the body, particularly in the pancreas. Insulin plays a crucial role in lowering blood glucose levels, thus preventing them from spiking after meals. By consistently taking Eurepa 0.5 Tablet as prescribed, individuals can effectively control their blood glucose levels. This control is vital in reducing the risk of serious complications associated with diabetes, such as kidney damage, eye issues, nerve problems, and even limb loss. Incorporating this medication into a routine alongside a balanced diet and regular exercise regimen can contribute to a healthier and more normalized lifestyle for those managing diabetes. Eurepa 0.5 Tablet, containing Repaglinide, falls under the category of anti-diabetic medicines and is especially recommended for individuals with uncontrolled high blood sugar levels that are not adequately managed through diet and exercise alone. Its unique mechanism of action involves stimulating the release of insulin from the pancreas rapidly after eating, effectively regulating blood sugar levels post-meal. This medication can be used alone or in conjunction with other treatments as part of a comprehensive approach including dietary modifications and physical activity to effectively manage blood sugar levels.
How to use the Eurepa 0.5 Tablet
To properly use Eurepa 0.5 Tablet, follow the advice of your doctor regarding the dose and how long to take it for. This tablet should be taken on an empty stomach. Swallow it whole with water, and do not chew, crush, or break it. It is important to follow these instructions carefully to ensure that the medication works effectively. If you have any questions or concerns about how to use this tablet, consult your doctor or pharmacist for guidance.
Uses of Eurepa 0.5 Tablet
Eurepa 0.5 Tablet is utilized in the treatment of Type 2 diabetes mellitus, a condition characterized by high blood sugar levels resulting from insulin resistance or deficient insulin production. It is beneficial for individuals with Type 2 diabetes to help manage their blood glucose levels effectively. By taking Eurepa 0.5 Tablet as prescribed by a healthcare professional, patients with Type 2 diabetes mellitus can regulate their blood sugar levels and reduce the risk of complications associated with the condition.
What conditions Eurepa 0.5 Tablet treats?
Eurepa 0.5 Tablet is commonly used for the management of Diabetes mellitus type 2. This condition, also known as adult-onset diabetes, results in elevated blood sugar levels due to insulin resistance or insufficient insulin production by the pancreas. Typically affecting individuals over 40 years old, it can also occur in younger individuals based on risk factors. The treatment approach often involves oral glucose-lowering medications along with insulin therapy to help regulate blood sugar levels effectively.
Should you consult a doctor?
It is important to seek medical attention if you experience persistent side effects like hypoglycemia (low blood sugar levels), abdominal pain, nausea, diarrhea, back pain, joint pain, inflammation of sinus, or other worrying symptoms while taking Eurepa 0.5 Tablet. Contact your doctor if you are concerned about any side effects or if they do not go away, as they may require medical intervention. Additionally, consult your doctor before taking this medicine if you have a history of kidney disease, heart or pancreas issues, or if you consume alcohol regularly. Pregnant or breastfeeding women should also seek medical advice before using Eurepa 0.5 Tablet. It is essential to keep your healthcare provider informed about all medications you are taking to avoid any potential interactions. Regular monitoring through tests like kidney function and blood glucose levels may be necessary to ensure the effectiveness of the treatment.
Side effects of Eurepa 0.5 Tablet
When taking Eurepa 0.5 Tablet, some possible side effects may occur. It's important to note that most side effects are temporary and tend to go away as your body gets used to the medication. However, if you experience persistent or concerning side effects, it is advised to consult your doctor. Common side effects of Eurepa 0.5 Tablet may include hypoglycemia, which is a low blood glucose level that can cause symptoms such as abdominal pain, nausea, and diarrhea. Other potential side effects include back pain, joint pain, upper respiratory tract infections, headaches, and sinus inflammation. In some cases, you may also experience symptoms like stomach pain, signs of a common cold, diarrhoea, joint pain, and back pain.
Safety advice

liver
When considering Eurepa 0.5 Tablet for your treatment, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment while using this medication. It is strongly advised to consult your doctor before starting Eurepa 0.5 Tablet. If you have severe liver disease, it is best to avoid using this medication. Prior medical advice is crucial in such cases.

kidney
Eurepa 0.5 Tablet requires caution in severe kidney disease. Adjustments to the dose may be necessary. Consult your doctor before use.

alcohol
It is not safe to drink alcohol while taking Eurepa 0.5 Tablet.

driving
When taking Eurepa 0.5 Tablet, be cautious while driving; low or high blood sugar can affect your ability to drive. Avoid driving if experiencing related symptoms.

pregnancy
Eurepa 0.5 Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before using this medication.

breastfeeding
Eurepa 0.5 Tablet is not recommended during breastfeeding as it may pass into breastmilk and harm the baby. Please consult your doctor before use during this time.
Consumption warning before consuming Eurepa 0.5 Tablet
Before consuming Eurepa 0.5 Tablet, it is crucial to note that these tablets should not be used by individuals with type 1 diabetes or diabetic ketoacidosis. This medication may lead to hypoglycemia, necessitating the adjustment of dosage if other antidiabetic drugs are being taken. It is important not to stop taking Eurepa 0.5 Tablet abruptly without doctor's advice. Patients are advised to maintain a healthy diet with adequate calories and avoid strenuous exercises to mitigate the risk of low blood sugar. Pregnant or breastfeeding individuals, as well as those under 18 or over 75 years, should avoid this medication. Prior to starting treatment, inform your doctor if you have cardiac issues, a history of stroke, low blood pressure, or severe liver/kidney disease. Alcohol consumption is not recommended while using Mage 0.5mg Tablets due to the potential for lactic acidosis.
Disease interactions
When considering the use of Eurepa 0.5 Tablet, it is important to note that individuals with specific health conditions should exercise caution. Patients suffering from kidney problems, liver issues, cardiovascular disease, or low blood sugar levels should avoid using Eurepa 0.5 Tablet as it may potentially exacerbate their condition. It is crucial for those with these health issues to consult their healthcare provider before starting this medication to ensure their safety and well-being. These interactions can impact the effectiveness and safety of the drug, highlighting the importance of personalized medical advice in managing one's health.
What if you forgot to take Eurepa 0.5 Tablet?
If you forget to take a dose of Eurepa 0.5 Tablet, simply skip the missed dose and resume your usual dosing schedule. It is important not to take a double dose to make up for the missed one. This will help maintain the correct level of medication in your system and reduce the risk of potential side effects. It's best to follow the regular dosing instructions provided by your healthcare provider.
Related lab tests
Related Lab Tests for Eurepa 0.5 Tablet include Glucose - Fasting Blood, Glucose - Postprandial Blood, and Glycosylated Hemoglobin. These tests are important to monitor blood sugar levels and the effectiveness of the medication in managing diabetes. The Glucose - Fasting Blood test measures the level of sugar in the blood after fasting for a certain period, providing valuable information about how well the body is able to regulate blood sugar levels. The Glucose - Postprandial Blood test, done after a meal, helps to evaluate how the body processes sugar after eating. Lastly, the Glycosylated Hemoglobin test gives an average of blood sugar levels over the past few months, offering insight into long-term blood sugar control. These tests play a crucial role in assessing the impact of Eurepa 0.5 Tablet on diabetes management.
Additional Information
Habit Forming | No |
Chemical Class | Meglitinide Derivative |
Therapeutic Class | ANTI DIABETIC |
Action Class | Meglitinides (Insulin Secretogogues) |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹180.55
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024